Rajnish Wellness Ltd. is positioned weakly compared to its peers, showing no revenue growth, zero profitability metrics, and a significant overvaluation relative to its financial performance. In contrast, other companies like Sun Pharmaceutical and Cipla exhibit strong growth and profitability, making them sector leaders. The analysis identifies potential value picks and highlights financially weak companies within the sector.

• • Rajnish Wellness Ltd. has no revenue growth and zero profitability metrics.
• • Sun Pharmaceutical and Cipla are strong performers with high revenue growth and profitability.
• • Rajnish is significantly overvalued with a PE ratio of 785.71, which is far higher than peers.